Trump Secures MFN Pricing Deals with Nine More Pharma Manufacturers

President Trump announced agreements with nine additional pharmaceutical manufacturers to adopt Most-Favored-Nation pricing, ensuring U.S. drug prices are no higher than the lowest price paid by any other nation. The deals extend the MFN framework beyond the initial wave of manufacturers targeted under the executive order issued earlier in 2025.